Evidence map›Paper›PMID 39816026›Full record

ArticleJournal of gastrointestinal oncology2024

The potential role of tumor deposits in the prognosis and TNM staging for colorectal cancer.

Xinhong Shi, Lin Lu, Zihan Wang, Yingying Dai, Shuyi Hu, Zipeng Wu, Ruofan Yu, Tianyi Liu, Yingying Jiang, Yuxin Ma and 7 more

Abstract read
In one paragraph

Article in Journal of gastrointestinal oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Xinhong Shi *Department of Oncology, The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing, China.ORCID https://orcid.org/0000-0003-0261-5239
Lin Lu *Department of Radiotherapy, The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing, China.
Zihan Wang *Department of Clinical Medicine, Nantong University, Nantong, China.
Yingying Dai *Department of Radiotherapy, The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing, China.
Shuyi HuDepartment of Oncology, The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing, China.
Zipeng WuDepartment of Oncology, The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing, China.
Ruofan YuDepartment of Oncology, The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing, China.
Tianyi LiuDepartment of Radiotherapy, The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing, China.
Yingying JiangDepartment of Hematology and Oncology, Geriatric Hospital of Nanjing Medical University, Jiangsu Province Geriatric Hospital, Nanjing, China.
Yuxin MaDepartment of Oncology, The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing, China.
Bo ShenDepartment of Oncology, The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing, China.
Guoren ZhouDepartment of Oncology, The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing, China.
Emerson Y ChenDivision of Hematology & Medical Oncology, Knight Cancer Institute, Department of Medicine, Oregon Health & Science University, Portland, OR, USA.
Cheng ChenDepartment of Radiotherapy, The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing, China.
Lili ZhaoDepartment of Oncology, Affiliated Huishan Hospital of Xinglin College, Nantong University, Wuxi Huishan District People's Hospital, Wuxi, China.
Yue ShiDepartment of Oncology, The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing, China.
Xiaohua WangDepartment of Oncology, The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Tumor deposits (TDs) can impact proper staging of cancer, which is crucial for discussing prognosis and determining the appropriate treatment plan. Our study aimed to correlate how TDs influence prognosis of resected colorectal cancer (CRC) and how to optimize tumor-node-metastasis (TNM) staging with respect to TDs for clinical decision-making. Methods: A retrospective analysis was performed on 611 patients with CRC treated in Jiangsu Cancer Hospital from January 1, 2010 to December 31, 2020 among whom 197 had TDs. The influence and distribution characteristics of TDs on the median overall survival (mOS) of patients with CRC were quantitatively and qualitatively analyzed, and the differences in mOS between different subgroups were also analyzed. Results: Patients with TDs had a shorter mOS (only 60.3±3.9 months) than did patients without TDs. TDs had a more significant association with the survival of M0 patients, and there were significant differences in the prognosis of M0 patients with stage pN0 and pN1c or stage pN0, pN1, and pN2. The combination of lymph node metastases (LNMs) and TDs was associated with mOS. The proportion of rectal cancer, papillary tissue type, and nerve invasion was higher in the TD-positive group, and proportion of metastasis to the brain, spleen, lung, and bone in this groups was also higher. Subgroup analysis showed that the degree of tumor differentiation, the depth of tumor invasion, vascular invasion, nerve invasion, liver metastasis, lung metastasis, bone metastasis, peritoneal metastasis, ovarian metastasis, pelvic and abdominal metastasis, and the number of distant metastases were associated with the prognosis of patients with CRC. Conclusions: TDs were closely correlated with the poor prognosis of patients with CRC. Greater attention should be paid to improving the quality of pathological reports in clinical decision-making and the comprehensive assessment of patients' baseline characteristics so that accurate prognosis and corresponding treatment plan can be properly communicated with patients.

Indexed as

Colorectal cancer (CRC)tumor deposits (TDs)tumor-node-metastasis staging (TNM staging)

Identifiers

PMID39816026
PMCPMC11732349

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.